Literature DB >> 6373932

Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis.

C L Jaffe, E Bennett, G Grimaldi, D McMahon-Pratt.   

Abstract

Sixteen species-specific monoclonal antibodies were produced against membranes of Leishmania donovani. These antibodies only reacted with determinants present on L. donovani. No cross-reactions were found with any other species of Leishmania or with membranes of Trypanosoma cruzi. An extensive analysis of the binding specificities of selected antibodies was carried out by using whole promastigote homogenates as antigen. Monoclonal antibodies D-1, D-2, D-3, and D-4 correctly identified all 44 L. donovani stocks from a cross-panel of 84 New and Old World Leishmania stocks. Antibodies D-1 and D-2 were also useful for species classification by immunofluorescence. No cross-reactions were observed with any other Leishmania species examined. Based on either Western blot and/or radioimmunoprecipitation analyses, five distinct groups of molecules associated with L. donovani-specific antigenic determinants were identified. These molecules range in m.w. from 18 to 84 kilodaltons. The antigenic molecules recognized by antibodies D-2, D-10, and D-13 are also recognized by antibodies present in sera from patients with visceral leishmaniasis (kala-azar). Kala-azar sera obtained from cases in both the Old and New World specifically compete with these monoclonal antibodies for the appropriate antigenic determinants in Western blot analysis. These monoclonal antibodies and/or the purified protein antigens may be useful in the development of a serologic assay for the clinical diagnosis of visceral leishmaniasis caused by L. donovani and in epidemiologic studies of leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373932

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Ca2+ signaling in the transformation of promastigotes to axenic amastigotes of Leishmania donovani.

Authors:  A Prasad; S Kaur; N Malla; N K Ganguly; R C Mahajan
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

2.  Monoclonal antibody affinity purification of a Leishmania membrane glycoprotein and its inhibition of leishmania-macrophage binding.

Authors:  C S Chang; K P Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

3.  Variation in antigenic determinants specific to the infective stage of Trypanosoma cruzi.

Authors:  R A Wrightsman; W Leon; J E Manning
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

4.  Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis.

Authors:  E Ghedin; W W Zhang; H Charest; S Sundar; R T Kenney; G Matlashewski
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

5.  Monoclonal antibody affinity purification of a 78 kDa membrane protein of Leishmania donovani of Indian origin and its role in host-parasite interaction.

Authors:  Mandira Mukherjee; Anindita Bhattacharyya; Swadesh Duttagupta
Journal:  J Biosci       Date:  2002-12       Impact factor: 1.826

6.  DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.

Authors:  Gannavaram Sreenivas; B V Subba Raju; Ruchi Singh; Angamuthu Selvapandiyan; Robert Duncan; Dwijen Sarkar; Hira L Nakhasi; Poonam Salotra
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Monoclonal antibodies as diagnostics; an appraisal.

Authors:  M Z Siddiqui
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

8.  Immunoblot analysis of the humoral immune response to Leishmania donovani infantum polypeptides in human visceral leishmaniasis.

Authors:  L Rolland-Burger; X Rolland; C W Grieve; L Monjour
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

9.  Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.

Authors:  J Champsi; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

10.  Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients.

Authors:  M Chatterjee; K Basu; D Basu; D Bannerjee; N Pramanik; S K Guha; R P Goswami; S K Saha; C Mandal
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.